Your source for expert insights into the future of healthcare. Factide delivers in-depth coverage of biotechnology, medical engineering, and the AI-driven innovations transforming global health outcomes with precision and speed.
Free-living amoebae in water systems are spreading globally, posing a dual threat as pathogens and carriers of other microbes. Rising temperatures and aging infrastructure demand urgent action.
A study reveals exercise-induced mitochondrial transfer via platelets reduces stroke damage in mice, offering insights into potential therapeutic strategies.
Insilico Medicine's Science MMAI Gym trains AI models for drug discovery tasks like molecular design and protein interaction prediction.
Myopia rates are projected to affect 50% of the global population by 2050, with emerging research linking gut health to disease progression and innovative treatments showing promise in slowing vision loss.
New research reveals how chemotherapy-induced gut damage alters microbiota to produce a metabolite that enhances anti-cancer immunity.
Study reveals giant Ice Age kangaroos hopped in short bursts for predator evasion, challenging movement assumptions.
New research shows inflexible work schedules correlate with lower physical health outcomes, highlighting barriers to preventive care access during working hours.
A 15-year study links lifelong physical inactivity to higher stress markers in midlife, emphasizing the role of sustained exercise in mitigating chronic stress effects.
Alterity Therapeutics outlines 2025 milestones and 2026 strategic goals in biotech advancements. Discover their roadmap for therapeutic development and clinical trials.
A groundbreaking study ranks humans seventh in monogamy, showing a 66% full sibling rate, placing them alongside beavers and meerkats in a unique social context compared to other primates.
UCLA researchers challenge organic chemistry norms by creating unstable 3D molecules with non-integer bond orders, offering new possibilities for drug design.
Hundred Health integrates wearables, blood tests, and medical records into personalized health protocols. The company emphasizes a 'decision layer' to translate data into actionable plans, supported by evidence-based models from BellSant.
